Randomised, double-blind, placebo controlled, study to evaluate the safety and efficacy of acetyl L-carnitine (ALCAR), in combination with antiretroviral therapy, for prevention of distal symmetric polyneuropathy (DSP) and lipid abnormalities in treatment of human immunodeficiency virus (HIV)

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2005
INTERVENTION: Randomised controlled trial CONDITION: Distal symmetric polyneuropathy (DSP) ; Nervous System Diseases ; Other polyneuropathies PRIMARY OUTCOME: Primary endpoint: the change in baseline in total area of PGP (protein gene product) immunostaining on the epidermis at 48 weeks SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: 40 patients
Epistemonikos ID: 2a5a5669558d77747ad0229bb987033c56e45f95
First added on: Mar 20, 2020